Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine renoprotective effect in HBV-related liver cirrhosis
NCT01799486Phase 4Unknown
- Start
- Feb 2013
- Primary completion
- Feb 2013
01
Overview
A Phase 4 trial of telbivudine in hepatitis B virus infection, Liver cirrhosis (LC). Status: unknown.
02
Drugs
telbivudine
03
Conditions
hepatitis B virus infectionLiver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01799486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01799486.